Peng Yuan
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Topics
- Cancer Treatment and Pharmacology (41 papers)Breast Cancer Treatment Studies (40 papers)HER2/EGFR in Cancer Research (33 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Peng Yuan
136 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 951
- Molecular Biology 806
- Cancer Research 735
- Pulmonary and Respiratory Medicine 392
- Radiology, Nuclear Medicine and Imaging 226
Countries citing papers authored by Peng Yuan
This map shows the geographic impact of Peng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yuan more than expected).
Fields of papers citing papers by Peng Yuan
This network shows the impact of papers produced by Peng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yuan. The network helps show where Peng Yuan may publish in the future.
Co-authorship network of co-authors of Peng Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Yuan. A scholar is included among the top collaborators of Peng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Yuan. Peng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | Circular RNA hsa_circ_0068033 Acts as a Diagnostic Biomarker and Suppresses the Progression of Breast Cancer Through Sponging miR-659 | 1 |
| 12 | 21 | |
| 13 | 8 | |
| 14 | 1 | |
| 15 | 16 | |
| 16 | 9 | |
| 17 | 3 | |
| 18 | 3 | |
| 19 | [Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for Her-2 status in breast cancer and its relationship to clinicopathological characteristics]. | 4 |
| 20 | 44 |
About Peng Yuan
Peng Yuan is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 148 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (41 papers), Breast Cancer Treatment Studies (40 papers) and HER2/EGFR in Cancer Research (33 papers). The work is most often cited by research in Cancer Research (735 citations), Oncology (951 citations) and Pulmonary and Respiratory Medicine (392 citations). Peng Yuan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fei Ma, Binghe Xu, Binghe Xu, Pin Zhang, Juanjuan Ou, Ying Fan, Songlin Gao, Jiayu Wang, Ruigang Cai and Qing Li. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.